Related Experiment Video
Updated: Jun 5, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
Bioresponsive controlled release using mesoporous silica nanoparticles capped with aptamer-based molecular gate
Chun-Ling Zhu1, Chun-Hua Lu, Xue-Yuan Song
1The Key Lab of Analysis and Detection Technology for Food Safety of the MOE, College of Chemistry and Chemical Engineering, Fuzhou University, Fuzhou 350002, PR China.
This study introduces a novel aptamer-based system for controlled drug release using mesoporous silica nanoparticles. Aptamer-target interactions trigger the release of therapeutic cargo, offering a promising platform for targeted nanomedicine.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Controlled-release systems are crucial for targeted drug delivery.
- Mesoporous silica nanoparticles (MSNs) offer high surface area and tunable pore sizes for drug encapsulation.
- Aptamer-target interactions provide high specificity for biomolecule recognition.
Purpose of the Study:
- To design and demonstrate a novel bioresponsive controlled-release system using aptamer-modified mesoporous silica nanoparticles.
- To utilize aptamer-target interactions for triggered cargo release.
- To explore the potential of this system for targeted nanomedicine applications.
Main Methods:
- Fabrication of mesoporous silica nanoparticles.
- Modification of gold nanoparticles with aptamers (ATP aptamer used as a model).
- Capping of MS nanoparticle pores with aptamer-modified gold nanoparticles.
- Demonstration of cargo release triggered by competitive displacement reaction with ATP molecules.
Main Results:
- Successful design of a bioresponsive controlled-release system based on aptamer-modified MS nanoparticles.
- Demonstrated triggered cargo release via aptamer-ATP competitive displacement.
- Validated the potential of aptamer-target interactions for precise control over nanodevice function.
Conclusions:
- Aptamer-target interactions represent a viable strategy for developing custom-controlled nanodevices.
- The developed aptamer-based controlled-release system shows broad applicability, particularly for cancer biomarker targeting.
- This platform holds promise for advanced targeted drug delivery and nanomedicine.
More Related Videos
11:53Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
Published on: July 21, 2017
10:07Preparation of Multifunctional Silk-Based Microcapsules Loaded with DNA Plasmids Encoding RNA Aptamers and Riboswitches
Published on: October 8, 2021
Related Concept Videos
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Classification
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Rate-Programmed I
Modified-Release Drug Delivery Systems: Site-Targeted